Browse studies

Find your next paid study

1,513 recruiting studies matching your filters

Contextual Word Learning in Children With Developmental Language Disorder

Many children have developmental language disorder, which makes it difficulty to learn language, including vocabulary, and results in ongoing academic and soci…

Developmental Language Disorder

Estimated

~$10 – $6,250

Binghamton UniversityNCT05988190

A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients With DCIS Following Breast Conserving Therapy

This is a prospective, non-interventional (observational) cohort study conducted within the medical network of the participating investigators and institutions…

DCISStage 0 Breast CancerDuctal Breast Carcinoma In Situ

A Phase 1a, Dose Escalation, Safety and Tolerability Study of NX-1607, a Casitas B-lineage Lymphoma Proto-oncogene (CBL-B) Inhibitor, in Adults With Advanced Malignancies, With Phase 1b Expansion in Select Tumor Types

This is a first-in-human Phase 1a/1b multicenter, open-label oncology study designed to evaluate the safety and anti-cancer activity of NX-1607 in patients wit…

Ovarian Cancer, EpithelialGastric CancerGastroEsophageal Junction (GEJ) Cancer+11 more

Estimated

~$10 – $8,750

Nurix Therapeutics, Inc.

Community and NYC Public Healthcare System Partnership to Promote Equitable Access to Language Services and Optimal Preventive Health Services Use Among Individuals With Limited English Proficiency

This is a community-based study that will engage community and health care stakeholders to develop, implement, and evaluate a Health Literacy (HL)-informed, cu…

Appropriate Use of Language Across Services

Estimated

~$10 – $1,125

NYU Langone HealthNCT06272110

Observational

Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation

The goal of this clinical trial is to evaluate the effectiveness of a social network intervention to recruit people who inject drugs and their networks for HIV…

HIV InfectionsSubstance Use DisordersAddiction+3 more

Estimated

~$10 – $6,250

Johns Hopkins UniversityNCT06103370

Phase 2

Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects With Non-Small Cell Lung Cancer With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

To assess: * efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification, solid …

Solid TumorsAdvanced CancerRenal Cancer+15 more

Estimated

~$10 – $8,750

Apollomics Inc.NCT03175224

Observational

Patient-centered, Optimal Integration of Survivorship and Palliative Care

The goal of this study is to develop and test the feasibility of a supportive care model (POISE) for patients with metastatic Non-small Cell Lung Cancer (NSCLC…

Stage IV Non-small Cell Lung CancerTargeted TherapyNonsmall Cell Lung Cancer+5 more

Estimated

~$10 – $6,250

Massachusetts General HospitalNCT04900935

Phase 1

A Phase I Microtrial With PLZ4-Coated Paclitaxel-Loaded Micelles (PPM) in Patients With Recurrent or Refractory Non-Myoinvasive Bladder Cancer

This phase I trial tests the safety, tolerability and effectiveness of PLZ4-coated paclitacel-loaded micelles (PPM) in treating patients with non-muscle invasi…

Recurrent Non-Muscle Invasive Bladder CarcinomaStage 0a Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8+1 more

Estimated

~$10 – $6,250

University of California, DavisNCT06173349

Observational

Short-term And Longer-term Cognitive Impact Of Hourly Neurochecks In Acute Brain Injury

The proposed research plan seeks to understand the impact of sleep disruption in the Neurological Intensive Care Unit (ICU) on older patients with acute brain …

Intracerebral Hemorrhage

Estimated

~$10 – $6,250

University of California, San DiegoNCT06219889

Phase 1

A Phase I Study of SNDX 5613 (Revumenib) as Post-Transplant Maintenance After Allogeneic Hematopoietic Cell Transplant in Patients With KMT2A-Rearranged or NPM1-Mutated Acute Leukemia

This phase I trial tests the safety, side effects, best dose and effectiveness of revumenib in treating patients with acute leukemia after allogeneic stem cell…

Acute LeukemiaAcute Leukemia of Ambiguous LineageAcute Lymphoblastic Leukemia+5 more

Estimated

~$10 – $6,250

City of Hope Medical CenterNCT06575296

Phase 1

CAFs (Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC): a Phase I/II Study

The purpose of this study is to see if adding pirfenidone to atezolizumab will increase anti tumor activity and reduce treatment resistance in stage 4 and recu…

NSCLC Stage IVNSCLC, Recurrent

Estimated

~$10 – $6,250

University of Kansas Medical CenterNCT04467723

Phase 2

A Randomized, Multi-Cohort Phase II Trial of Temozolomide and Atezolizumab for Subsequent Line Treatment for Small Cell Lung Cancer

This phase II trial studies the effects of temozolomide and atezolizumab as second or third line treatment for patients with small cell lung cancer that has sp…

Extensive Stage Lung Small Cell CarcinomaMetastatic Lung Small Cell CarcinomaRecurrent Lung Small Cell Carcinoma+3 more

Estimated

~$10 – $7,500

Dwight OwenNCT04919382